Assertio Therapeutics
ASRT
#9047
Rank
A$0.13 B
Marketcap
$1.42
Share price
5.09%
Change (1 day)
-11.56%
Change (1 year)

P/E ratio for Assertio Therapeutics (ASRT)

P/E ratio as of December 2024 (TTM): 0.4412

According to Assertio Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0.4412. At the end of 2022 the company had a P/E ratio of 1.88.

P/E ratio history for Assertio Therapeutics from 2001 to 2023

2005201020152020-200-1001000companiesmarketcap.com

PE ratio at the end of each year

Year P/E ratio Change
20221.88-101.72%
2021-1093760.42%
2020-2.82584.42%
2019-0.4125-106.63%
20186.22-226.03%
2017-4.94-60.53%
2016-12.5-12.34%
2015-14.3-299.38%
20147.16-49.24%
201314.1-223.06%
2012-11.5-394.32%
20113.89-95.1%
201079.5-1120.45%
2009-7.7951.09%
2008-5.16-258.17%
20073.26-191.66%
2006-3.56-62.06%
2005-9.3833.68%
2004-7.0123.64%
2003-5.67166.58%
2002-2.13-43.88%
2001-3.79

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-0.9953-325.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.76-1,405.45%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.